Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNP3A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,411
Award facts
- Contract value 100% obligated
- $2,411.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,411.08 by the Defense Logistics Agency (DLA) for Actemra 162 mg/0.9 ml syringes. The contract represents a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and was competitively awarded without set-aside provisions. This award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
The delivery order supports the federal government's medical supply chain requirements, providing a branded pharmaceutical product essential for military and veteran healthcare systems. AmerisourceBergen's significant presence as a prime contractor within the DLA's pharmaceutical procurement ecosystem reflects the company's capability to fulfill federal medical supply needs across a diverse portfolio of medications and medical commodities. The DLA Troop Support Medical IDC represents a critical contracting vehicle that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with pharmaceutical and medical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FNP3A?
SPE2DR26FNP3A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FNP3A worth?
The government has obligated $2,411 on SPE2DR26FNP3A.
Is contract SPE2DR26FNP3A an order under another contract?
Yes. SPE2DR26FNP3A is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNP3A competed?
The extent of competition for SPE2DR26FNP3A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award